{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT05313529","recordId":"NCT05313529","peptideSlug":"liraglutide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct05313529-liraglutide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05313529.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct05313529.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2022-03-28","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-03-28","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"fadccd2337c856d850b3bf9f0561f1fbe444c5d5396ad1bedd875099f68da70a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2022-08-23","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-08-23","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"737faedd3855236e4bbfb7500d0e71456fc7de75aa717e743154c8d89e069df9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Outcome Measures","Sponsor/Collaborators","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2022-09-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-09-06","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"b643bf6b4d2e8dc07e2a54ea6d0e1acc12ad446fbd250c5fb693c129ee17558b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2022-10-08","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2022-10-08","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"681942d7d2b11bbbc30df207229b83e2a32ec3641730f236735ac745f836b5a9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=4&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Study Status"],"historyVersion":5,"lastUpdateSubmitQcDate":"2023-05-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2023-05-15","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"8b3ea62db744d8e3b013e4cd5e4e8e9cac0a19fe7b06ca35b2b776026921c31a","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=5&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Eligibility","IPDSharing","Outcome Measures","Sponsor/Collaborators","Study Description","Study Identification","Study Status"],"historyVersion":6,"lastUpdateSubmitQcDate":"2024-03-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-03-19","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"a14cef2952c7c80ffe2162d8803abcc7ed5cc74d958fb7f24f552aea118d6e00","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=6&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Identification","Study Status"],"historyVersion":7,"lastUpdateSubmitQcDate":"2024-05-30","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-05-30","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"5b43a438e362fa4aafd961ca90f9d7ed7b3e6d57f41d0085cf3b05ab88406140","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=7&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Eligibility","Outcome Measures","Sponsor/Collaborators","Study Description","Study Design","Study Identification","Study Status"],"historyVersion":8,"lastUpdateSubmitQcDate":"2024-09-10","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-09-10","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"17edb07fb7a0ecdfacbb5f44e9e19a3dd0b33358c7fc570ac2b6f0cac4c7fb57","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=8&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":9,"lastUpdateSubmitQcDate":"2024-10-15","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"liraglutide","submittedDate":"2024-10-15","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"3aff1620345ace47004aad3c0de18cac4d7cbb50c27e9a72ec5403d8fd9d339f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=9&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":10,"lastUpdateSubmitQcDate":"2025-05-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-05-17","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"1944fa1ca1605aebcc97a37f4bdefea9c818a8ec6ecb102f1840db8125bcf77f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=10&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Study Status"],"historyVersion":11,"lastUpdateSubmitQcDate":"2025-06-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-06-24","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"676eba2471c4182db459c5703ce01d8735a8df4c2f85bd11dbe3e8784b286220","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=11&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Description","Study Identification","Study Status"],"historyVersion":12,"lastUpdateSubmitQcDate":"2025-11-18","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2025-11-18","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"144409861e3b1192b672a53dcc1cc969ea5a91b4bd1837a441267f904dfb9fcf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=12&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["IPDSharing","Outcome Measures","References","Study Status"],"historyVersion":13,"lastUpdateSubmitQcDate":"2026-01-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"liraglutide","submittedDate":"2026-01-03","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"6b4afdf01483aae5cbf79ce79454b520c42b50744783817fa02ce8a25cf6d2b9","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=13&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Study Design","Study Status"],"historyVersion":14,"lastUpdateSubmitQcDate":"2026-07-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-07-21","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"f20ab6fd354c7c1c12234afd7b070d8eeb7ff2528d205881600a6bfdd2a6f24b","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=14&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Document Section","Oversight","Study Status"],"historyVersion":15,"lastUpdateSubmitQcDate":"2026-08-03","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"liraglutide","submittedDate":"2026-08-03","publishedAt":"2026-08-23","recordId":"NCT05313529","recordSha256":"5fa0cb49ba26e3adb6f5c2547f2619775b794ffab54333ec5786bfca8f3a01c5","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT05313529?a=15&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"3f5a22ef9e4fbd40caed0127d53fe64507ed50ea3baae40307d652db7e25b0bc"}}